Health Agency Nominations, Health Policy Changes, and Cancer Treatment Costs
This week’s BioBlog focuses on Trump’s health agency nominations, cancer treatment costs, expected health insurance company profitability in 2017, and expected health policy changes for the upcoming legislative session.
Johns Hopkins reports that individuals on medicare who don’t have a supplemental plan pay huge out of pocket costs.
The Wall Street Journal reports that given Trump’s picks for the top health positions it is likely that he plans to have health policy at the forefront.
Donald Trump has nominated Price and Verma as top healthcare agency picks. It is expected that the democrats may try and block Price since he has heavily criticized the affordable care act.
Various cancer healthcare policies, including the Part B demo, are still sitting in limbo as congress adjourned for Thanksgiving.
According to the Fitch Ratings, insurance companies can expect decreased profitability in 2017.